rs3789806

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004333.6(BRAF):​c.1992+16G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.176 in 1,609,598 control chromosomes in the GnomAD database, including 37,044 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 10808 hom., cov: 32)
Exomes 𝑓: 0.16 ( 26236 hom. )

Consequence

BRAF
NM_004333.6 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 0.313
Variant links:
Genes affected
BRAF (HGNC:1097): (B-Raf proto-oncogene, serine/threonine kinase) This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 7-140749271-C-G is Benign according to our data. Variant chr7-140749271-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 40393.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-140749271-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.658 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
BRAFNM_001374258.1 linkuse as main transcriptc.2112+16G>C intron_variant ENST00000644969.2 NP_001361187.1
BRAFNM_004333.6 linkuse as main transcriptc.1992+16G>C intron_variant ENST00000646891.2 NP_004324.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
BRAFENST00000644969.2 linkuse as main transcriptc.2112+16G>C intron_variant NM_001374258.1 ENSP00000496776
BRAFENST00000646891.2 linkuse as main transcriptc.1992+16G>C intron_variant NM_004333.6 ENSP00000493543 P4

Frequencies

GnomAD3 genomes
AF:
0.298
AC:
45280
AN:
151876
Hom.:
10759
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.664
Gnomad AMI
AF:
0.104
Gnomad AMR
AF:
0.181
Gnomad ASJ
AF:
0.198
Gnomad EAS
AF:
0.174
Gnomad SAS
AF:
0.310
Gnomad FIN
AF:
0.153
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.142
Gnomad OTH
AF:
0.267
GnomAD3 exomes
AF:
0.199
AC:
49747
AN:
250290
Hom.:
7572
AF XY:
0.199
AC XY:
26914
AN XY:
135304
show subpopulations
Gnomad AFR exome
AF:
0.674
Gnomad AMR exome
AF:
0.0994
Gnomad ASJ exome
AF:
0.205
Gnomad EAS exome
AF:
0.186
Gnomad SAS exome
AF:
0.313
Gnomad FIN exome
AF:
0.149
Gnomad NFE exome
AF:
0.142
Gnomad OTH exome
AF:
0.179
GnomAD4 exome
AF:
0.163
AC:
237989
AN:
1457604
Hom.:
26236
Cov.:
32
AF XY:
0.167
AC XY:
121127
AN XY:
725174
show subpopulations
Gnomad4 AFR exome
AF:
0.680
Gnomad4 AMR exome
AF:
0.109
Gnomad4 ASJ exome
AF:
0.206
Gnomad4 EAS exome
AF:
0.156
Gnomad4 SAS exome
AF:
0.313
Gnomad4 FIN exome
AF:
0.142
Gnomad4 NFE exome
AF:
0.136
Gnomad4 OTH exome
AF:
0.195
GnomAD4 genome
AF:
0.299
AC:
45378
AN:
151994
Hom.:
10808
Cov.:
32
AF XY:
0.296
AC XY:
21990
AN XY:
74278
show subpopulations
Gnomad4 AFR
AF:
0.665
Gnomad4 AMR
AF:
0.180
Gnomad4 ASJ
AF:
0.198
Gnomad4 EAS
AF:
0.174
Gnomad4 SAS
AF:
0.309
Gnomad4 FIN
AF:
0.153
Gnomad4 NFE
AF:
0.142
Gnomad4 OTH
AF:
0.268
Alfa
AF:
0.125
Hom.:
340
Bravo
AF:
0.312
Asia WGS
AF:
0.280
AC:
974
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)May 19, 2015- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 25, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all): 4109/13006=31.59% -
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 12, 2019Variant summary: BRAF c.1992+16G>C alters a non-conserved nucleotide located close to a canonical splice site and therefore could affect mRNA splicing, leading to a significantly altered protein sequence. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.2 in 250290 control chromosomes, predominantly at a frequency of 0.67 within the African or African-American subpopulation in the gnomAD database, including 3698 homozygotes. Therefore, suggesting the variant is the major allele in population(s) of African American origin. Three ClinVar submissions (evaluation after 2014) cite the variant as benign. Based on the evidence outlined above, the variant was classified as benign. -
Benign, no assertion criteria providedclinical testingGreenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic CenterJan 15, 2015- -
RASopathy Benign:2
Benign, criteria provided, single submitterclinical testingGeneDx-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not provided Benign:1Other:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
Lung cancer;C0346629:Colorectal cancer;C1835047:Melanoma, cutaneous malignant, susceptibility to, 1;C3150970:Noonan syndrome 7;C3150971:LEOPARD syndrome 3;C4551602:Noonan syndrome 1;CN029449:Cardiofaciocutaneous syndrome 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsDec 12, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
12
DANN
Benign
0.50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3789806; hg19: chr7-140449071; COSMIC: COSV56062530; API